Condensational Growth of Combination Drug-Excipient Submicrometer Particles for Targeted High Efficiency Pulmonary Delivery: Comparison of CFD Predictions with Experimental Results
- 27 September 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Pharmaceutical Research
- Vol. 29 (3), 707-721
- https://doi.org/10.1007/s11095-011-0596-1
Abstract
Purpose The objective of this study was to investigate the hygroscopic growth of combination drug and excipient submicrometer aerosols for respiratory drug delivery using in vitro experiments and a newly developed computational fluid dynamics (CFD) model. Methods Submicrometer combination drug and excipient particles were generated experimentally using both the capillary aerosol generator and the Respimat inhaler. Aerosol hygroscopic growth was evaluated in vitro and with CFD in a coiled tube geometry designed to provide residence times and thermodynamic conditions consistent with the airways. Results The in vitro results and CFD predictions both indicated that the initially submicrometer particles increased in mean size to a range of 1.6–2.5 μm for the 50:50 combination of a non-hygroscopic drug (budesonide) and different hygroscopic excipients. CFD results matched the in vitro predictions to within 10% and highlighted gradual and steady size increase of the droplets, which will be effective for minimizing extrathoracic deposition and producing deposition deep within the respiratory tract. Conclusions Enhanced excipient growth (EEG) appears to provide an effective technique to increase pharmaceutical aerosol size, and the developed CFD model will provide a powerful design tool for optimizing this technique to produce high efficiency pulmonary delivery.Keywords
This publication has 36 references indexed in Scilit:
- Improving the Lung Delivery of Nasally Administered Aerosols During Noninvasive Ventilation—An Application of Enhanced Condensational Growth (ECG)Journal of Aerosol Medicine and Pulmonary Drug Delivery, 2011
- Numerical Model to Characterize the Size Increase of Combination Drug and Hygroscopic Excipient Nanoparticle AerosolsAerosol Science and Technology, 2011
- Characterization of Respiratory Drug Delivery with Enhanced Condensational Growth using an Individual Path Model of the Entire Tracheobronchial AirwaysAnnals of Biomedical Engineering, 2010
- Evaluation of Enhanced Condensational Growth (ECG) for Controlled Respiratory Drug Delivery in a Mouth-Throat and Upper Tracheobronchial ModelPharmaceutical Research, 2010
- Characterization of Nanoaerosol Size Change During Enhanced Condensational GrowthAerosol Science and Technology, 2010
- CFD simulations of enhanced condensational growth (ECG) applied to respiratory drug delivery with comparisons to in vitro dataJournal of Aerosol Science, 2010
- Evaluation of the Respimat Soft Mist Inhaler using a Concurrent CFD and In Vitro ApproachJournal of Aerosol Medicine and Pulmonary Drug Delivery, 2009
- Effectiveness of Direct Lagrangian Tracking Models for Simulating Nanoparticle Deposition in the Upper AirwaysAerosol Science and Technology, 2007
- Theoretical Analysis of Hygroscopic Growth Rate of Mainstream and Sidestream Cigarette Smoke Particles in the Human Respiratory TractAerosol Science and Technology, 1998
- Aspects of Computer Simulation of Liquid-Fueled CombustorsJournal of Energy, 1983